Targeting hepatic kisspeptin receptor ameliorates nonalcoholic fatty liver disease in a mouse model.

J Clin Invest · 2022 · PMC9106350 · PMID 35349482

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

KPA-treated DIAMOND mice showed a trend toward increased levels of plasma ketone bodies ( Figure 9I ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.